| Schweiger, Christian (Shield Therapeutics 2008– CSO + Co-founder before Encysive Pharmaceuticals before Actelion) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Iron Therapeutics (Switzerland) AG |
Switzerland |
| Schweighoffer, Tamás (Forty51 Advisors 202204– Partner + Co-Founder) |
Partner (venture partner) |
Forty51 Ventures (Group) |
Switzerland |
| Schweikhard, Lutz (Univ Greifswald 201007 Professor + Director of Institute of Physics) |
Professor |
University of Greifswald |
Germany |
| Schweins, Thomas (Qiagen 200402– VP Corporate Strategy before Boston Consulting Dusseldorf before Hoechst) |
Corporate Strategy Manager |
Qiagen (Group) |
Netherlands |
| Schweitzer, Gretchen (Trophic Comunications 201801 before MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Schweitzer, Markus |
n. a. |
Sanofi (Group) [since May 2011] |
Germany |
| Schweizer, Christoph (Dräger 201801 President Corporate Strategy + Business Development) |
Business Development Manager / Strategy Manager |
Dräger (Group) |
Germany |
| Schweizer, Pascal (Thermosome GmbH 201604 Managing Director + Co-Founder) |
Managing Director |
Thermosome GmbH |
Germany |
| Schwenzer, Anette (Promega 201101 Promega GmbH Head Digital Marketing/PR) |
Sales Manager / Marketing Manager |
Promega (Group) |
Germany |
| Schwer, Heinz (ViraTherapeutics 201705– CEO before Lanthio Pharma + Sloning BioTechnology CEO + Founder) |
Chief Executive Officer (CEO) |
Boehringer Ingelheim (Group) |
Austria |
| Schwerin, Manfred (Leibniz-Gemeinschaft 201109 Head FBN Dummerstorf) |
President/Director/Head Business Group/Unit/Division |
Leibniz-Gemeinschaft |
Germany |
| Schwertner-Knoll, Dagmar (BioGenes GmbH 201302 Marketing/Sales Director) |
Sales Manager / Marketing Manager |
BioGenes Gesellschaft für Biopolymere mbH (BioGenes GmbH) |
Germany |
| Schwiezer, Jürgen (Roche Diagnostics GmbH –200605– designated CEO Division Roche Diagnostics 200801) |
Chief Executive Officer (CEO) |
Roche (Group) |
Germany |
| Schwille, Petra (Max Planck 202212 Managing Director of MPI of Biochemistry) |
Managing Director |
Max Planck Society for the Advancement of Science |
Germany |
| Schwind, Tobias (German Tech Transfer Management 202207 Managing Partner at FTTF) |
Managing Partner (investment firm) |
German Tech Transfer Management GmbH |
Germany |
| Schüberg, Staffan (Esteve 202001 CEO before Lundbeck) |
Chief Executive Officer (CEO) |
Esteve (Group) |
Spain (España) |
| Schühsler, Helmut M. (TVM) |
n. a. |
TVM (Group) |
Germany |
| Schülein, Thomas (Bruker 201308 President of Bruker Nano Analytics division) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
|
| Schüler, Frank (Forevery Healthy 202209 COO + Kizoo Managing Director) |
Chief Operating Officer (COO) |
Forever Healthy (Kizoo / Michael Greve) (Group) |
Germany |
| Schüler, Julia (BioMedServices 201101– before BioRegion Rhein-Neckar 200910–201012 Managing Director + E&Y Mannheim) |
consulting (economic) |
Bio.Aspekte – Dr. Julia Schüler |
Germany |
| Schüller, Alexander (Cellvie 202101 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellvie (Group) |
Switzerland |
| Schüller, Stephan (Indivumed 202112– CFO before Bankhaus Lampe KG + Vereins- und Westbank AG) |
Chief Financial Officer (CFO) |
Indivumed (Group) |
Germany |
| Schüller, Thorsten (CureVac 201911 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
CureVac (Group) |
Germany |
| Schüller, Ulrich |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Schüller, Wolfgang (Lipotec GmbH + Frankfurt BioTech Alliance e. V. before Aventis Research and Technologies 200205) |
Managing Director |
Sanofi (Group) [since May 2011] |
Germany |
| Schüren, Reinhard (November AG 200609– CEO) |
Chief Executive Officer (CEO) |
November (Group) |
Germany |
| Schürmann, Anja (Biofrontera 200801– Director Marketing before Galderma) |
Sales Manager / Marketing Manager |
Biofrontera (Group) |
Germany |
| Schürmann, Hans |
n. a. |
Holtzbrinck (Group) |
|
| Schütte, Georg (BMBF 201202 State Sectretary) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
| Schütte, Stefan (Agilent 200903 Senior Marketing Director Liquid Chromatography Business) |
Sales Manager / Marketing Manager |
Agilent (Group) |
United States (USA) |
| Schütz, Christian (btov Partners 201907 Managing Director) |
Managing Director |
btov Partners (b-to-v Partners) (Group) |
Switzerland |
| Schütze, Karin (CellTool GmbH 201912 Managing Director + Co-Founder) |
Managing Director |
CellTool GmbH |
Germany |
| Schüßler, Andrea (Huber & Schüßler 200809 Founding Partner) |
Attorney / Lawyer |
Huber & Schüssler Patentanwälte (Munich) |
Germany |
| Schächtele, Christoph (ProQinase 200805 CEO) |
Chief Executive Officer (CEO) |
Klinik für Tumorbiologie Freiburg (KTB) (Tumor Biology Center Freiburg) |
Germany |
| Schädler, Barbara (Roche 202111 Media Relations) |
Public Relations Manager / Investor Relations Manager |
Roche (Group) |
Switzerland |
| Schäfer, Bernd-Josef (Endress+Hauser 201801 Managing Director of Endress+Hauser Flowtec) |
Managing Director |
Endress+Hauser (Group) |
Switzerland |
| Schäfer, Christoph (CIS Pharma 202307 CEO) |
Chief Executive Officer (CEO) |
CIS Pharma AG |
Switzerland |
| Schäfer, Elmar (Biogenerix 200503) |
n. a. |
Merckle (Group) |
Germany |
| Schäfer, Frank (BioEcho Life Sciences 202203 Managing Director + Co-Founder) |
Managing Director |
BioEcho (Group) |
Germany |
| Schäfer, Gerhard (Novartis/Sandoz + before Hexal + Stada + Noll + Azupharma) |
n. a. |
Novartis (Group) |
Germany |
| Schäfer, Gisbert (AB SCIEX 201009 Senior Director EMEA) |
Regional manager |
Danaher (Group) |
Germany |
| Schäfer, Jan (Sartorius 202405 Head of Seperation Systems) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Schäfer, Jochen (GATC Biotech 201011 Director Custom Sequencing) |
Laboratory Manager (industry) |
Eurofins (Group) |
Germany |
| Schäfer, Klaus (202402 business angel + advisor + former CTO of Covestro) |
Consultant (economic/technology) |
Cycle GmbH |
Germany |
| Schäfer, Klaus (Altana Pharma 200503) |
n. a. |
Takeda (Group) |
Germany |
| Schäfer, Mathias (Univ Cologne 201004 Head Mass Spec Lab at Institute for Organic Chemistry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Cologne (Universität zu Köln) |
Germany |
| Schäfer, Ralf (Bruker Corp 201303 Bruker Daltonics MADI-TOF Product Manager) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
| Schäfer-Korting, Monika (FU Berlin 200507) |
n. a. |
Freie Universität Berlin (FU Berlin, Free University Berlin) |
Germany |
| Schäferkordt, Jan |
n. a. |
Miltenyi Biotec (Group) |
Germany |
| Schäffer, Michael (Probiodrug 201810– CBO joined 201808 as EVP Business + Strategy before Crelux + Sireen) |
Business Development Manager / Strategy Manager |
Vivoryon (Group) |
Germany |
| Schätzle, Sebastian (Enzymicals 202203– CBO before Alchemab Therapeutics) |
Chief Business Officer (CBO) |
Enzymicals AG |
Germany |
| Schöfer, Sebastian (High-Tech Gründerfonds 201409 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Schöllauf, Moritz (Nyra Health 202306 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Nyra Health GmbH |
Austria |
| Schön, Heiko (Merck (DE) 201508– Manager Group Strategy joined Merck in 2005) |
Corporate Strategy Manager |
Merck (DE) (Group) |
Germany |
| Schön-Feltes, Silvia (NRW 201010 PROvendis responsible for Biology) |
IP Manager |
Provendis GmbH (Patentagentur NRW) |
Germany |
| Schönauer, David (Aminoverse 202003– CEO before SeSaM-Biotech GmbH 201212–202002 Managing Director) |
Chief Executive Officer (CEO) |
Aminoverse B.V. |
Netherlands |
| Schöndorf, Martin (Laboratoires Réunis 201711 Director Business Unit) |
n. a. |
Laboratoires Réunis (LU) |
Luxembourg |
| Schöndube, Jonas (Cytena GmbH 201403– Managing Director + Co-Founder) |
Managing Director |
Bico (Group) |
Germany |
| Schönenberger, Helmut (TU München 202407 CEO + Co-Founder of UnternehmerTUM) |
n. a. |
Technical University Munich (TU München, TUM) |
Germany |
| Schönfeld, Kirsten (Q-Bioanalytic GmbH 200902 Managing Director) |
Managing Director |
Eurofins (Group) |
Germany |
| Schönfeld, Wolfgang (Eucodis 200808c CEO) |
Chief Executive Officer (CEO) |
Biosynth (since 9/22) (Group) |
Austria |
| Schönhaar, Tobias (Amathaon Capital 202110 Managing Director + Co-Founder) |
Managing Director |
Amathaon Capital UG (haftungsbeschränkt) |
Germany |
| Schöning, Jan (Boehringer 201509 Head Global Technology + Innovation Management Biopharmaceuticals) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Schöpflin, Jan (Eckert & Ziegler 202412 Marketing) |
Sales Manager / Marketing Manager |
Eckert & Ziegler (Group) |
Germany |
| Schöwel-Wolf, Verena J. J. (MyoPax 202208 CEO) |
n. a. |
MyoPax (Group) |
Germany |
| Scimeca, Dario (Precision BioSciences 201906– General Counsel before Genentech + Cooley LLP + Heller Ehrman LLP) |
General Counsel / Chief Legal Officer (CLO) |
Precision BioSciences (Group) |
United States (USA) |
| Scodari, Joseph C. (Actelion –201107 Board Director RESIGNED 8/11) |
Board member, non-executive |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
| Scordis, Phil (UCB 201209 Director of Informatics) |
IT manager |
UCB (Group) |
Belgium |
| Scorici, Gabriela (BigOmics 202203 Marketing Specialist) |
Sales Manager / Marketing Manager |
BigOmics Analytics S.A. |
Switzerland |
| Scots-Knight, Denise (formerly Pollard-Knight) (Mereo BioPharma 201507 CEO before Managing Partner at Phase4 Ventures) |
Chief Executive Officer (CEO) |
Mereo BioPharma Group Ltd. |
United Kingdom (GB) |
| Scott, Kalina (Polyphor 201706– CFO before Bank am Bellevue + UBS + KPMG) |
Chief Financial Officer (CFO) |
Spexis (Group) |
Switzerland |
| Scott, Nerida (JnJ 202009 Head JnJ Innovation EMEA) |
Business Development Manager / Strategy Manager |
Johnson & Johnson (JnJ) (Group) |
United Kingdom (GB) |
| Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board) |
Chief Executive Officer (CEO) |
Basilea (Group) |
Switzerland |
| Scott, Steve (Holtzbrinck 202311 Director of Portfolio Development at Digital Science) |
Business Development Manager / Strategy Manager |
Holtzbrinck (Group) |
United Kingdom (GB) |
| Scriba, Jürgen (Advalytix co-founder) |
n. a. |
Danaher (Group) |
Germany |
| Searle, Susan (Imperial Innovation 200511 CEO) |
Chief Executive Officer (CEO) |
IP Group (Group) |
United Kingdom (GB) |
| Sebald, Walter |
n. a. |
University of Würzburg |
Germany |
| Sebastian, Dirk (Ganymed Pharmaceuticals AG 201309 CFO + COO) |
Chief Financial Officer (CFO) |
Astellas (Group) |
Germany |
| Sebhatu, Jared (German Accelerator Life Sciences 201604 Program Director Germany before VDI) |
Business Development Manager / Strategy Manager |
digital health transformation eG (dht) |
Germany |
| Sedgwick, Jonathon (AbbVie 202210 VP + Global Head of Discovery Research before Boehringer) |
Research & Development Manager |
AbbVie (Group) |
United States (USA) |
| Seeberger, Peter H. (MPI of Colloids and Interfaces 2009– Director before ETH Zurich Prof before MIT Prof) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Seefeldt, Christian H. (MeVis Medical Solutions 200901–201009 CFO resigned 201009 before Saperion AG + Haitec AG) |
Chief Financial Officer (CFO) |
Varian Medical Systems (Group) |
Germany |
| Seegers, Christian (Berlin (govt) 201111 Senior Investment Manager Life Science at IBB Beteiligungsges) |
Investment Manager |
Berlin (govt region) |
Germany |
| Seehofer, Horst (Germany (govt) 200809 Minister of Agriculture) |
Minister |
Germany (govt) |
Germany |
| Seeley, Michael (Swixx Biopharma 202105 Co-Founder) |
Company Founder |
Swixx Biopharma (Group) |
Switzerland |
| Seeling, Matthes (LBO France 202411 Investment Director) |
Investment Manager |
LBO France (Group) |
France |
| Seewald, Michael (Bayer HealhCare 200506) |
n. a. |
Bayer (Group) |
Germany |
| Seewald, Sascha (Caterna GmbH 201101 Managing Director) |
Managing Director |
Caterna Vision GmbH |
Germany |
| Segeberg, Friederike (Merck (DE) 202002 Head Media Relations) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
| Segerros, Andreas (Sunstone Capital 201502 Partner) |
Partner (venture partner) |
Eir Ventures (Group) |
Sweden |
| Seghezzi, Graziano (Sofinnova Partners 200806 Partner) |
Partner (venture partner) |
Sofinnova (Group) |
France |
| Sehlke, Robert (Graph Therapeutics 202501 CTO + Co-Founder before Allcyte) |
Chief Technology/Technical Officer (CTO) |
Graph Therapeutics FlexCo (AT) |
Austria |
| Sehlmeyer, Rasa (HighQu GmbH 201504 Managing Director) |
Managing Director |
HighQu GmbH |
Germany |
| Seibert, Daniel (Life Technologies 201105 CFO of Geneart AG LEFT Geneart BEFORE 7/12) |
Chief Financial Officer (CFO) |
Thermo Fisher (Group) |
Germany |
| Seibert, Gloria S. (Temedica 202001 Managing Director + Co-Founder) |
Managing Director |
Temedica GmbH |
Germany |
| Seidel, Guido (Wacker 202007 Managing Director of Wacker Biotech GmbH + Head of Biopharma Business) |
Managing Director |
Wacker (Group) |
Germany |
| Seidel, Tino (AbbVie 202308 Director of Patient Engagement at AbbVie Germany) |
n. a. |
AbbVie (Group) |
Germany |
| Seidel, Uwe (XotonicsMED GmbH 201607 Managing Director) |
Managing Director |
XotonicsMED GmbH |
Germany |
| Seidel, Wolfgang (Advigen 201201 before Innogenetics 2005–2009 VP BusDev + Bayer Pharma 1981–2004) |
Consultant (economic/technology) |
Advigen Dr. Wolfgang Seidel Biotechnology Consulting |
Germany |
| Seidelmann, Oliver (Chiroblock GmbH 201109 Managing Director + co-founder) |
Managing Director |
ChiroBlock GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 75 76 77 ... 94 95 96 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
